This study was designed to investigate functional recovery after the transplantation of mesenchymal stem cells (MSCs) or neurally differentiated MSCs (NMSCs) derived from bone marrow in a rat model of spinal cord injury (SCI). Sprague-Dawley rats were subjected to incomplete SCI using an NYU impactor to create a free drop contusion at the T9 level. The SCI rats were then classified into three groups; MSCs, NMSCs, and phosphate-buffered saline (PBS)-treated groups. The cells or PBS were administrated 1 week after SCI. Basso-Beattie-Bresnahan (BBB) locomotor rating scores were measured at 1-week intervals for 9 weeks. Somatosensory evoked potentials (SSEPs) and motor evoked potentials (MEPs) were also recorded 8 weeks after transplantation. While transplantation of MSCs led to a clear tendency of motor recovery, NMSCtreated rats had significantly improved BBB scores and showed significantly shortened initial latency, N1 latency, and P1 latency of the SSEPs compared to PBS controls. In addition, 5-bromo-2-deoxyuridine (BrdU)-prelabeled MSCs costained for BrdU and glial fibrillary acidic protein (GFAP) or myelin basic protein (MBP) were found rostrally and caudally 5 mm each from the epicenter of the necrotic cavity 4 weeks after transplantation. These results suggest that neurally differentiated cells might be an effective therapeutic source for functional recovery after SCI.
INTRODUCTION
umbilical cord blood (UCB) (5, 13, 20, 23, 29) , and adipose tissue (9, 10) can be propagated in large quantities while retaining their multipotent ability to differentiate Recovery from spinal cord injury (SCI) is quite difficult because the central nervous system has a limited into different cell types.
Recently, BM-derived mesenchymal stem cells (MSCs) ability to regenerate injured cells, replace damaged myelin sheath, and reestablish functional connections. have been shown to be able to differentiate into neural lineage cells under specific in vitro conditions including Many patients with SCI have difficulty in walking and accomplishing daily activities during their remaining induction with β-mercaptoethanol, forskolin, or basic fibroblast growth factor (bFGF) (6, 17, 27) . Likewise, adult years. As a therapeutic approach in SCI, stem/progenitor cells or predifferentiated cells may provide a partial so-stem cells from BM are potentially suitable sources for cell-based therapy in SCI. In addition, BM-derived cells lution, although few successful clinical trials have been reported. For example, stem cells or progenitors from can overcome critical ethical issues of the embryonic stem cells and neural stem cells from human fetal tis-adult tissues such as bone marrow (BM) (1, 3, 12, 15, 24) , sues, which were well known to be able to differentiate Santa Cruz, CA, USA), PE-CD45 (BD Bioscience), FITC-CD54 (BD Bioscience) to label lympho-hemato-into oligodendrocytes or astrocytes, and regenerate the injured spinal cord (7, 18, 19) . poietic cells. NMSCs were incubated for one of the following markers: 1) βIII-tubulin using mAb TuJ1 (Co-This study was carried out to investigate whether neurally differentiated MSCs (NMSCs) derived from al-vance, NJ, USA), 2) NeuN (Chemicon, Pemecula, CA, USA), 3) glial fibrillary acidic protein (GFAP; Chemi-logeneic BM after exposure to appropriate environments can serve as an alternative cell source that maintains the con), 4) S100β (Chemicon), 5) CNPase (DAKO, Hamburg, Germany). In addition, cells were stained with capacity with possible potential to develop into neurons, astrocytes, and oligodendrocytes and whether NMSCs 4′ 6-diamino-2-phenylindole (DAPI; 1 µg/ml, Sigma-Aldrich) to visualize nuclei. may also be able to replace lost neural cells, remyelinate injured axons, and improve functional recovery in a rat Spinal Cord Injury model of SCI.
Animals were housed in a facility accredited by the
MATERIALS AND METHODS
Association for Assessment and Accreditation of Labo-Cell Culture and Maintenance ratory Animal Care (AAALAC). The Institution Review Board approved the experimental procedures. After all After obtaining BM aspirates of the femurs of adult rats were anesthetized with sodium pentobarbital (50 Sprague-Dawley rats (Orient, Sungnam, Korea) weighmg/kg, IP), the thoracic back area was shaved and disining 300-350 g, mononuclear cells (MNCs) (4-6 × 10 7 fected with povidone iodine, and a laminectomy was cells/ml) were separated using the Ficoll-Hypaque (Histhen performed at the T9 spinal cord level with the duratopaque-1077; Sigma-Aldrich, St. Louis, MO, USA) mater intact. Contused incomplete SCI was induced by density-gradient method. The BM-derived MNCs were dropping a 10-g weight rod from a 25-mm height onto then seeded on T25 or T75 culture flasks in mesenchythe exposed dorsal surface of the spinal cord using an mal stem cell growth media (MSCGM, Cambrex, Charles NYU impactor. During the recovery period, body tem-City, IA, USA). Cells were incubated in a humidified perature was maintained at 37°C in a heating chamber. atmosphere at 37°C with 5% CO 2 . They were subcul-
The postoperative care included bladder expression 1-2 tured when they reached 80-90% confluence, and used times per day until bladder function had recovered. Profor transplantation after 4-6 passages. For immunohistophylactic kanamycin (1 mg/kg) was regularly adminislogical usage, a portion of the cells was incubated with tered for 1 week after surgery. Among a total of 50 ani-30 µM 5-bromo-2-deoxyuridine (BrdU; Sigma-Aldrich) mals, nine rats were excluded from this experiment due for 3 days to label dividing cells before transplantation.
to asymmetrical spinal cord damage.
Neural Induction
Cell Transplantation To induce neural differentiation, rat MSCs were cul-One week after SCI, the injured rats were randomly tured according to a modified protocol from Woodbury assigned to three groups without bias: MSC-treated (n = et al. (27) . Briefly, MSCs after four passages were prein-16), NMSC-treated (n = 12), and PBS-treated (n = 13) duced with DMEM (Gibco, Grand Island, NY, USA), groups. Rats were fixed in a stereotaxic frame (Stoelting 20% FBS (Gibco), and 5 ng/ml bFGF (Sigma-Aldrich)
Co., Wood Dale, IL, USA). Using a 25-gauge cannula for 24 h. Thereafter, the medium was changed to speconnecting to 10-µl Hamilton syringe, a total of 10 µl cific medium containing DMEM with N2 supplement, of the cultured cells (2.5 × 10 5 cells) was transplanted 200 µM butylated hydroxyanisole, 25 mM KCl, 2 mM into the epicenter of the injury over a 10-min period valproic acid, and 10 µM forskolin (all from Sigma-(infusion rate, 60 µl/h) after reopening the wound. All Aldrich) to promote neurogenic differentiation. Cells rats received cyclosporine A (10 mg/kg, IP) daily from were then incubated in the neural induction medium for 2 days before the transplantation until the completion of 2-16 h at 37°C. this experiment to suppress immune rejection.
Immunocytochemistry
Behavioral Assessment Cells were fixed with 4% paraformaldehyde in 0.1 M phosphate-buffered saline (PBS) for 30 min, and
The Basso, Beattie, and Bresnahan (BBB) locomotor rating scale was used to measure functional recovery of blocked with 1% bovine serum albumin for 1 h at 37°C. This procedure was followed by incubation with a the rats. This scale measures hindlimb movements starting with a score of 0, indicating no observable move-FITC-conjugated hamster anti-rat CD29 mAb (BD Bioscience, San Jose, CA, USA) or RPE-conjugated mouse ment. Increasing scores are given for movement of individual joints, limb coordination, weight-supported plantar anti-rat CD90 mAb (BD Bioscience) to label MSCs and PE-CD31 (BD Bioscience), FITC-CD34 (Santa Cruz, stepping, etc., up to a maximum score of 21, which indi-cates normal movement. Two investigators observed the and tissues were serially immersed in 6%, 15%, and 30% sucrose until the tissues sank down. The tissues hindlimb movements in an open field for 5 min after rats were gently adapted to the field. Locomotor func-were frozen and cryosectioned longitudinally at 12 µm thick using a cryomicrotome (Microm/HM500V, Wall-tions were scored weekly from day 1 to 9 weeks after SCI. The score was obtained by averaging the value of dorf, Germany). Sections were then immunostained for BrdU and various markers of neural cells. Individual both limbs. A total of 23 rats (9 MSC-, 7 NMSC-, 7 PBS-treated rats) survived to the end of the experiment.
sections were incubated for one of the following markers overnight: 1) βIII-tubulin (Covance) at 1:400, 2) Electrophysiological Study NeuN (Chemicon), 3) GFAP (Chemicon), 4) myelin basic protein (MBP) (Chemicon). The sections were incu-Somatosensory evoked potentials (SSEPs) (n = 6 each) and motor evoked potentials (MEPs) (n = 5 each) bated with Alexa 488 or 563 secondary antibodies at 1: 400 for 1 h, then washed, mounted on glass slides with were measured 8 weeks after transplantation. The rats were randomly assigned to the recording of SSEPs or fluorescent mounting medium (Vectorshield, Vector), and examined under a fluorescence microscope (BX51, MEPs without any indication of the extent of the lesion. The animals were anesthetized with urethane (1.25 g/kg, Olympus, Tokyo, Japan) or an argon and krypton laser scanning confocal imaging system (LSM 510, Zeiss, IP). They were also treated with atropine sulfate (0.8 mg/kg, IP) to reduce tracheal secretions, and pancuro-Gottingen, Germany) to confirm double-labeled cells by visualizing the colocalization for BrdU and the cell type-nium bromide (1.0 mg/kg, IP) to induce muscle relaxation. The rats were then intubated with a tracheostomy specific markers at a magnification of 600×. and artificially respired using an animal respirator (Har-Statistical Analysis vard Apparatus, South Natik, MA, USA). The left sciatic nerve was exposed and a pair of electrodes was Statistical comparison of the BBB scores were perhooked around the nerve. A single square pulse of elecformed using a repeated ANOVA followed by post hoc trical stimulation was delivered with a stimulus isolator Bonferroni comparison through SPSS version 13.0. The (A365, World Precision Instruments, New Haven, CT, latencies and amplitudes of SSEPs or MEPs among USA), which was driven by a pulse generator (Pulsegroups were also analyzed using a one-way ANOVA master A300, World Precision Instruments, New Haven, with post hoc comparison. Values of p < 0.05 were ac-CT, USA) with a 0.1-ms pulse duration of stimuli and a cepted statistically significant. 6-mA intensity at 1-4 Hz. For the SSEP recording, a 4 × 4-mm-sized craniectomy was performed in the con-RESULTS tralateral frontoparietal area. A recording electrode (NE-Characterization of MSCs Derived From Allogeneic BM 120, Rhodes Medical Instruments, Tujunga, CA, USA)
Rat MSCs from allogeneic BM grew in a monolayer was fixed on the sensorimotor cortex at 2 mm posterior of large, flat cells at low plating densities. As the cells to bregma and 2 mm lateral to the sagittal suture after approached confluency, they assumed a more spindlecraniectomy. For the MEP recording, a laminectomy shaped, fibroblastic morphology. Using flow cytometry was performed at the L1 spinal cord level. Then, an analysis, undifferentiated rat MSCs were demonstrated electrode was inserted into the contralateral gray matter as negative for CD31, CD34, CD45, and CD54, which of the spinal cord near the motor conduction tracts. The surface markers associated with lympho-hematopoietic pointed tip of the electrode was used as an active eleccells ( Fig. 1a-d ). Using both flow cytometry analysis trode, and the rounded part of the electrode was used as and immunocytochemistry, cells were positive for CD29 a reference electrode. Each evoked potential consisted and CD90, which are reported to be surface markers of of an average of 100 single sweep epochs. MSCs ( Fig. 1e -i).
Immunohistochemistry
In Vitro Differentiation of MSCs Into Neural Among the subjects, nine rats (n = 3 each) were ran-Lineage Cells domly assigned to be sacrificed 4 weeks after transplantation. Nine rats (n = 3 each) were also sacrificed 8 NMSC was defined as MSC predifferentiated into neural lineage cells after neural induction medium. After weeks after transplantation. Animals were perfusion fixed transcardially with ice-cold PBS and 4% paraform-exposure to the specific medium, undifferentiated rat MSCs exhibited very rapid morphological changes. aldehyde, pH 7.4, to evaluate the characteristic phenotypes of the transplanted cells in vivo. Spinal cords were Most cells retracted their cytoplasm and formed a spherical cell body, extended cellular processes, and com-immediately removed, 20-mm-sized transverse segments of the injured region of the thoraco-lumbar spinal cord pletely stopped proliferating, compared to MSCs in basal conditions ( Fig. 2a, b) . After neurogenic differen-were dissected and stored in the same fixative overnight, Figure 1 . Characterization of rat MSCs by flow cytometry analysis and immunocytochemistry. Fluorescent intensity of each cell surface marker of undifferentiated MSCs (open peak) was compared to that of isotype control (shaded peak). Numbers of cells analyzed (event) was plotted on the y-axis and intensity of staining was plotted on the x-axis. Distribution of cells stained with antibodies to CD 31 (a), CD34 (b), CD 45 (c), and CD 54 (d) (opened), cell surface markers associated with lympho-hematopoietic cells, did not differ from those of isotype controls (shaded). However, fluorescence intensity of CD90 (e) and CD29 (f) (opened) as surface markers of the rat MSCs was greater (shifted to the right) than those of isotype (shaded). Immunocytochemistry showed the cells expressed CD 29 (g), CD 90 (h), and both of them (i) simultaneously, which could confirm the results of flow cytometry analysis. Scale bars: 10 µm. MSCs, mesenchymal stem cells. tiation, the cells showed intense expression of βIIImalfunctioning hindlimbs were excluded for this experiment. Although all rats exhibited a gradual improvement tubulin, NeuN, GFAP, S100β, and CNPase ( Fig. 2c-g) .
over time, the locomotor function of the NMSCs-treated Locomotor Function rats significantly continued to increase to a final score of 11.29 ± 0.57, whereas the function of the PBS-injected Behavioral performance was evaluated in all rats that received MSCs, NMSCs, or PBS using the BBB loco-animals was only maintained to a score of 7.86 ± 1.09 at 8 weeks posttransplantation (p < 0.05 by a repeated motor rating scale at weekly intervals for up to 9 weeks. Prior to transplantation at 1 week after SCI, the BBB measure ANOVA with post hoc Bonferroni comparison). The former score indicated a gait pattern character-testing was performed on all animals at 1 and 7 days post-SCI. A total of nine animals with asymmetrically ized by frequent weight-supported plantar steps. Some of the animals in the NMSCs-treated group showed oc-derived from BM had a clear tendency of functional recovery (Fig. 3) . casional forelimb and hindlimb coordination, whereas the latter score of the PBS controls indicated a hind-Electrophysiological Testing limb dysfunction characterized by sweeping or plantar placement with no weight support. On the other hand, SSEPs and MEPs were recorded 8 weeks after transplantation. The waves of the SSEPs and MEPs showed MSCs-treated rats did not show a statistical improvement with a final score of 10.44 ± 0.50 compared with representative patterns of negative-positive-negative potentials. The latencies of the evoked potentials were PBS controls (p = 0.128). Taken together, neurally differentiated cells provided a better outcome in locomo-measured from the onset of the first negative deflection (initial latency), from the peak of the first negative de-tor behavioral testing, even if transplantation of MSCs ; most cells retracted their cytoplasm, forming spherical cell body, emitted cellular protrusions, and completely stopped proliferating, compared to MSCs in basal conditions. After neurogenic differentiation, the cells showed intense expression of βIII-tubulin (c), NeuN (d), GFAP (e), S100β (f), CNPase (g), suggesting that rat MSCs had successfully differentiated into neural lineage cells, which consisted of progenitors of neurons, astrocytes, and oligodendrocytes. Cells were stained with DAPI to visualize nuclei. Scale bars: 10 µm. MSCs, mesenchymal stem cells. flection (N1 latency), and from the peak of the positive Immunohistochemistry deflection (P1 latency). The amplitudes were also mea-
The injured spinal cords exhibited cavitary lesions at sured from the peak of the first negative deflection to contused epicenter (Fig. 5a ). Transplanted cells derived the baseline (negative peak amplitude), from the peak of from allogeneic BM, which were prelabeled with the the first positive deflection to the baseline (positive peak cell proliferation marker BrdU, were confirmed by BrdU amplitude), and from the peak of the first negative destaining around the cavitary lesion of the injured spinal flection to the peak of the positive deflection (peak to cord in longitudinal sections. Double immunoreactivity peak amplitude) (Fig. 4a, b) .
for BrdU and various neural lineage markers showed NMSCs-transplanted rats showed a significantly that transplanted cells differentiated into astrocytes shortened initial latency of SSEPs (10.93 ± 1.37 ms) stained for GFAP or oligodendrocytes stained for MBP. compared with those of PBS controls (18.07 ± 2.41 ms) They were scattered rostrally and caudally 5 mm each (p < 0.05). In addition, N1 latency (23.20 ± 1.91 ms) (total 10 mm) from the epicenter of the injured spinal and P1 latency (51.55 ± 4.59 ms) of SSEPs in rats cord 4 weeks after transplantation (Fig. 5b, c) . However, treated with NMSCs were significantly shortened when definite neurons double-labeled with BrdU and βIIIcompared with those of PBS controls (36.35 ± 3.61 and tubulin or NeuN were not seen. In addition, transplanted 71.02 ± 5.33 ms, respectively) (p < 0.05) ( Table 1) . cells costained for BrdU and GFAP or MBP were not NMSCs-transplanted rats also tended to show increased observed in the spinal cord 8 weeks after transplantation, amplitude of the SSEPs compared with the PBS group, suggesting that most of the settled cells did not survive but NMSCs-treated animals exhibited neither a signifito that time point. cant improvement in latency nor amplitude of the MEPs DISCUSSION (Table 2) . On the other hand, MSCs-treated rats did not show any statistical difference in electrophysiological Functional recovery after SCI may be advanced with the use of cell-based therapy promoting strategic mecha-results, compared with PBS controls (Tables 1 and 2 ). . Electrophysiological studies after transplantation of BM-derived cells. SCI rats transplanted with NMSCs showed significantly shortened initial latency, N1 latency, and P1 latency of SSEPs (a) compared with PBS controls. They also had a clear tendency to show increased amplitude of SSEPs, whereas NMSCs-treated animals exhibited neither a significant improvement in latency nor amplitude of MEPs (b). NMSCs, neurally differentiated MSCs; SSEPs, somatosensory evoked potentials; MEPs, motor evoked potentials. nisms including cellular replacement for neurons or glial with BrdU and βIII-tubulin or NeuN, suggesting that neuronal cells had not settled down in vivo after trans-cells lost after SCI and trophic or paracrine support to surviving or replaced cells to increase survival and plas-plantation, despite the ability of MSCs to differentiate into various neural lineage cells in equal proportion in ticity. Before clinical trials, sufficient preclinical data regarding the biological mechanisms of neurological im-vitro. Differentiated astrocytes and oligodendrocytes also did not survive longer than 8 weeks posttransplanta-provement are required. Among experimental animal models in the laboratory setting, intralesional or intrave-tion, which was similar to what was reported in a previous study (4) . In addition, NMSC-transplanted rats nous transplantation of BM-derived cells has been proven to be useful for amelioration of the functional showed earlier functional improvement as measured by the BBB locomotor rating scale. Namely, most NMSC-deficit in various neurological diseases such as ischemic brain injury (2,28), demyelinating lesion (1, 12) , and SCI treated rats began exhibiting plantar placement 2 weeks posttransplantation, and showed plantar placement with (22, 30) . Recently, genetically modified BM cells overexpressing neurotrophic factors such as BDNF and weight support in their stance 3 weeks posttransplantation. These results suggested that functional recovery GDNF were used to maximize therapeutic effects (8, 14, 17, 21) . due to trophic support or paracrine effect by neurotrophic factors, cytokines, and neuroprotective factors In this study, we investigated neurogenic differentiation from allogeneic BM-derived MSCs with flow cy-secreted by neurally differentiated cells may be a more prominent therapeutic effect than the integration of the tometry and immunocytochemistry, and showed that almost all of neurally differentiated MSCs strongly ex-grafted BM cells and establishment of functional connections. It can be explained by reports that neurotrophic pressed βIII-tubulin, NeuN, GFAP, S100β, or CNPase, which indicated that they consisted of progenitors of factors such as BDNF, GDNF, NT-3, and NGF (11,25) or those secreted from transplanted stem cells (16) en-neurons, astrocytes, and oligodendrocytes in equal proportion. Intraspinal transplantation of the NMSCs hanced neural regeneration and improved neurological outcome, whereas it was reported that transdifferentia-promoted functional recovery after SCI. In particular, locomotor performance and latency of SSEPs were sig-tion of hematopoietic cells is extremely rare (26) . Because injured rats showed significant motor recov-nificantly improved in NMSC-treated rats, compared with those of PBS controls. Furthermore, transplanted ery at a relatively early stage after transplantation, and only a small number of transplanted cells survived in cells prelabeled with BrdU also differentiated into neural lineage cells that expressed specific markers for astro-the injured spinal cord for a limited period, we propose that trophic or paracrine support has a much greater im-cytes and oligodendrocytes 4 weeks after transplantation, even though the number of integrated cells was not pact on functional improvement. Our electrophysiological study also showed that the latency of the SSEPs was abundant. However, we did not find double-labeled cells tation with brain-derived neutrophic factor into the spinal cord injured rat. Acta Neurochir. 147:985-992; 2005.
